Daiwa Securities Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-69
| Closed | -$1K | – | 1329 |
|
|
2023
Q3 | $1K | Hold |
69
| – | – | ﹤0.01% | 1239 |
|
|
2023
Q2 | $1K | Hold |
69
| – | – | ﹤0.01% | 1260 |
|
|
2023
Q1 | $3K | Hold |
69
| – | – | ﹤0.01% | 1174 |
|
|
2022
Q4 | $3K | Hold |
69
| – | – | ﹤0.01% | 1184 |
|
|
2022
Q3 | $4K | Hold |
69
| – | – | ﹤0.01% | 1167 |
|
|
2022
Q2 | $3K | Hold |
69
| – | – | ﹤0.01% | 1189 |
|
|
2022
Q1 | $5K | Hold |
69
| – | – | ﹤0.01% | 1166 |
|
|
2021
Q4 | $5K | Hold |
69
| – | – | ﹤0.01% | 1187 |
|
|
2021
Q3 | $4K | Buy |
69
+31
| +82% | +$1.8K | ﹤0.01% | 1187 |
|
|
2021
Q2 | $2K | Hold |
38
| – | – | ﹤0.01% | 1134 |
|
|
2021
Q1 | $2K | Hold |
38
| – | – | ﹤0.01% | 1140 |
|
|
2020
Q4 | $2K | Sell |
38
-73
| -66% | -$3.84K | ﹤0.01% | 1117 |
|
|
2020
Q3 | $5K | Hold |
111
| – | – | ﹤0.01% | 1081 |
|
|
2020
Q2 | $6K | Hold |
111
| – | – | ﹤0.01% | 1082 |
|
|
2020
Q1 | $6K | Hold |
111
| – | – | ﹤0.01% | 1080 |
|
|
2019
Q4 | $7K | Sell |
111
-13
| -10% | -$820 | ﹤0.01% | 1076 |
|
|
2019
Q3 | $7K | Hold |
124
| – | – | ﹤0.01% | 1040 |
|
|
2019
Q2 | $10K | Hold |
124
| – | – | ﹤0.01% | 1041 |
|
|
2019
Q1 | $12K | Buy |
124
+19
| +18% | +$1.84K | ﹤0.01% | 1013 |
|
|
2018
Q4 | $7K | Hold |
105
| – | – | ﹤0.01% | 1015 |
|
|
2018
Q3 | $9K | Hold |
105
| – | – | ﹤0.01% | 1033 |
|
|
2018
Q2 | $12K | Hold |
105
| – | – | ﹤0.01% | 1030 |
|
|
2018
Q1 | $8K | Buy |
+105
| New | +$8K | ﹤0.01% | 1037 |
|